Beyond the arrhythmia, AF often signals broader pathological processes that impair cardiac function and reduce quality of life and life expectancy.5 Many of these conditions are closely linked to social determinants of health, disproportionately affecting populations with socioeconomic disadvantage. Effective AF management requires addressing both the arrhythmia and its underlying contributors.4 
C – Comorbidity and risk factor management
Warfarin
Natalie Cooper[/caption]
Professor Michael Kidd[/caption]
DAA program to be expanded in community pharmacies
The Dose Administration Aids (DAA) program will be available to 70,000 more patients each year through community pharmacies, with the Federal Government announcing increased...
Remote Australians at increased risk for diabetes complications
Mortality rates are four times higher for Indigenous patients with diabetes than non-Indigenous Australians, a report has found.
The Australian Institute of Health and Welfare...
Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
PSA’s critical role in 7CPA in spotlight
Federal Health Minister Greg Hunt has asserted the critical role that PSA will play in drafting the 7th Community Pharmacy Agreement (CPA), shaping the...
If catastrophe calls, include these ‘musts’ in your plan
It’s imperative that every pharmacy have a disaster plan, a clear written procedure on what to do, to eliminate delays getting deliveries to affected areas.
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
